# Reflect Scientific, Inc.: Form 10-Q for the period ended Mar 31, 2016

- Company: [Reflect Scientific, Inc.](/companies/rscf.md) (CIK 1103090)
- Form: 10-Q
- Filed: 2016-05-13
- Accepted by EDGAR: May 13, 2016, 15:26 ET
- Period: 2016-03-31
- Accession: 0001548123-16-000579
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1103090/000154812316000579/f10qq116v3.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1103090/000154812316000579/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $374.0k | us-gaap:Revenues |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $107.2k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $266.8k | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-01-01 to 2016-03-31 | $26.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | $36.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-01-01 to 2016-03-31 | −$143 | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | $35.9k | us-gaap:NetIncomeLoss |
| Cash and equivalents | at 2016-03-31 | $182.1k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $594.8k | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $658.7k | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $68.2k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $68.2k | us-gaap:Liabilities |
| Shareholders' equity | at 2016-03-31 | $590.6k | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 8,339 characters.

#### Special Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of our Company. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Annual Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance however, that management’s expectations will necessarily come to pass. Factors that may affect forward- looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest;

Changes in U.S., global or regional economic conditions;

Changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments;

Increased competitive pressures, both domestically and internationally;

Legal and regulatory developments, such as regulatory actions affecting environmental activities;

The imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls;

Adverse weather conditions or natural disasters, such as hurricanes and earthquakes, labor disputes, which may lead to increased costs or disruption of operations.

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

#### Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited Financial Statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three month period ended March 31, 2016, to the items disclosed as significant accounting policies in management's Notes to the Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2015.

#### Plan of Operation and Business Growth

Our efforts continue to be focused on increasing the sales of our life science consumables and detectors while, at the same time, working to commercialize our liquid nitrogen refrigeration products. Of those liquid nitrogen refrigeration products, the ultra-low temperature freezer is receiving highest priority. We also continue work on the refrigerated trailer, or “reefer.” We have our first manufactured unit operational, have conducted a number of road tests and are working to develop alliances with contract manufacturers for those products.

We also continue to focus on the expansion of our detector. We believe that the enhanced functionality of our new detector, coupled with its low cost, provides us with a competitive edge over products currently being sold in that specialized market.

Concurrent with the development and commercialization of the above products, we have completed our on-line catalog and are making progress in enrolling new distributors for our consumable products.

Our revenues during the three month reporting periods increased 13% during 2016 compared to 2015 revenues.

#### Results of Operations

#### Three Months Ended March 31, 2016 and 2015

|  | For the three months ended March 31, 2016 | 2015 | Change |
| --- | ---: | ---: | ---: |
| Revenues | $373,964 | $313,222 | $60,742 |
| Cost of goods sold | 107,180 | 121,317 | (14,137) |
| Gross profit | 266,784 | 191,905 | 74,879 |
| Operating expenses | 230,751 | 193,627 | 37,124 |
| Other income (expense) | (143) | (29,553) | 29,410 |
| Net income (loss) | $35,890 | $(31,275) | $67,165 |

Revenues increased during the quarter ended March 31, 2016, to $373,964 from $313,222 for the quarter ended March 31, 2015, an increase of $60,742. The 2016 increase results from the sale of ultra-low temperature freezers which generated revenue of $115,670. Freezer sales in 2015 resulted in revenue of $29,150. We are continuing work to refine and commercialize the ultra-low temperature freezer technologies.

With increased sales during the reporting period, cost of goods decreased in the quarter ending March 31, 2016, as compared to March 31, 2015, to $107,180 from $121,317, a decrease of $14,137. We realized a gross profit percentage of 71% for the three months ended March 31, 2016, compared to 61% for the three months ended March 31, 2015. The gross profit percentage is dependent on the mix of product sales, which varies from quarter to quarter. The ultra-low temperature freezers provide higher gross margins than do our laboratory supplies. We continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on all product lines.

Operating expenses increased to $230,750 in the three months ended March 31, 2016, an increase of $37,123 over the expenses of $193,627 incurred in the three month period ended March 31, 2015. After working very hard to reduce our operating expenses in 2015, we recognized that costs would increase in 2016 as we began to record sales of the ultra-low temperature freezers and reefers. Advertising is required to generate leads and the sales are generally made through brokers who charge a commission on the sales transactions. While we continue to monitor and minimize operating costs, we also realize that certain levels of expenditures are required in order to commercialize the products and achieve market penetration.

The net profit for the three month period ended March 31, 2016 was $35,891, an improvement of $67,165 from the $31,275 loss for the three month period ended March 31, 2015. Management continues to look for opportunities to increase sales, improve gross margins and control ongoing operating expenses.

The net profit of $35,890 for the three month period ended March 31, 2016 represents earnings of $0.01 per share. This compares to the net loss of $31,275, or $(0.00) per share for the three months ended March 31, 2015.

#### Seasonality and Cyclicality

We do not believe our business is cyclical.

#### Liquidity and Capital Resources

Our cash resources at March 31, 2016, were $182,141, with accounts receivable of $210,039, net of allowance, and inventory of $199,497, net of allowance. Our working capital on March 31, 2016, was $526,623. Working capital on December 31, 2015 was $486,280.

For the three month period ended March 31, 2016, net cash used by operating activities was $107,121 which compares to $96,177 net cash provided from operating activities for the three month period ended March 31, 2015.

### Off-Balance Sheet Arrangements

We lease office and warehouse space under a non-cancelable operating lease in Utah which runs through November 30, 2017. Future minimum lease payments under the operating lease at March 31, 2016, are $62,000 for that facility. In addition, on May 9, 2014, the Company entered into an automobile lease. Future minimum lease payments under this lease are $9,984 at March 31, 2016, with minimum lease payments of $5,616 due for the remainder of 2016 and $4,368 in 2017.

## Controls and procedures

As filed, 2,086 characters.

### (a)

### Evaluation of Disclosure Controls and Procedures.

As of the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management, including our Chief Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures are not effective at that reasonable assurance level as of the end of the period covered by this report based upon our current level of transactions and staff. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote

### (b)

### Changes in Internal Control Over Financial Reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act. Management reviewed our internal controls over financial reporting, and there have been no changes in our internal controls over financial reporting for the quarter ended March 31, 2016 that have materially affected, or are like to affect, our internal controls over financial reporting.

Filed May 13, 2016.
Source: SEC EDGAR, the filing index for accession 0001548123-16-000579. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.
